Nyxoah (NYXH)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

Nyxoah (NYXH) is down 65.9% since the beginning of the year. At $2 per share, NYXH is trading 81.7% below its 52-week high of $9.

Nyxoah (NYXH) has returned -65.87% so far this year and -79.64% over the past 12 months.

Based on dividend-adjusted daily data since Jul 2, 2021, NYXH's average daily return is -0.12%, while the average monthly return is -2.55%.

Historically, 32% of months were positive and 68% were negative. The best month was Jan 2024 with a return of +133.2%, while the worst month was Jun 2026 at -47.3%. The longest winning streak lasted 2 consecutive months, and the longest losing streak was 6 months.

On a daily basis, NYXH closed higher 42% of trading days. The best single day was Jan 31, 2024 with a return of +32.9%, while the worst single day was Jun 5, 2026 at -49.7%.

Nyxoah has an annualized alpha of -31.34%, beta of 0.60, and R2 of 0.02 versus S&P 500 Index. Calculated based on daily prices since July 02, 2021.

• This stock participated in 237.64% of S&P 500 Index downside but only 64.35% of its upside - more exposed to losses than it benefited from rallies.
• Beta of 0.60 may look defensive, but with R2 of 0.02 this stock is largely uncorrelated with S&P 500 Index - low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
• R2 of 0.02 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

NYXH ranks 4 for risk / return — in the bottom 4% of stocks on our site. This means you're taking on significantly more risk than the returns justify. Consider whether the potential upside is worth the volatility, or explore alternatives with better risk / return profiles.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the Nyxoah. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Nyxoah was 96.46%, occurring on Jun 10, 2026. The portfolio has not yet recovered.

The current Nyxoah drawdown is 95.76%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of Nyxoah over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how Nyxoah is priced in the market compared to other companies in the Medical Instruments & Supplies industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.